Table 2. Subsidiary test results, clinical characteristics, and outcomes of the patients included in the study (N = 375).
Hospital admission exams | Normal range | |
---|---|---|
Hemoglobin (g/dl) | 12.0–16.0 | 13.0 ± 2.1 |
Total leukocytes (n/mm3) | 4,000–8,000 | 8,117 (5,500–11,200) |
Total lymphocytes (n/mm3) | 1,000–3,900 | 974 (699–1489) |
Platelets (n/mm3) | 150,000–400,000 | 179,000 (141,000–231,750) |
Serum creatinine (mg/dl) | 0.6–1.3 | 1.16 (0.90–1.78) |
D-dimer (ng/ml) | < 0.5 | 1.5 (0.7–9.1) |
C-reactive protein (mg/dl) | < 0.1 | 15.5 (7.6–25.1) |
Pulmonary involvement on tomography | ||
Mild, % (n) | 13.1 (49) | |
Moderate, % (n) | 32.0 (120) | |
Severe, % (n) | 39.7 (149) | |
Unknown, % (n) | 15.2 (57) | |
Severity score at ICU admission | ||
SAPS 3 | 54 (46–66) | |
Unknown, % (n) | 42.9 (161) | |
Mechanical ventilation, % (n) | 88.5 (332) | |
Organ dysfunctions during hospitalization | ||
Circulatory, % (n) | 85.3 (320) | |
Pulmonary, % (n) | 78.7 (295) | |
Coagulopathy, % (n) | 30.4 (114) | |
Hepatic | ||
Yes, % (n) | 13.3 (50) | |
No, % (n) | 73.3 (275) | |
Unknown, % (n) | 13.3 (50) | |
Kidney, % (n) | 100.0 (375) | |
Medications | ||
Azithromycin + hydroxychloroquine, % (n) | 37.6 (141) | |
Other antibiotics, not azithromycin | ||
Yes, % (n) | 85.9 (322) | |
No, % (n) | 2.7 (10) | |
Unknown, % (n) | 11.5 (43) | |
Corticosteroids, % (n) | 60.3 (226) | |
Continuous heparin infusion | ||
Yes, % (n) | 23.7 (89) | |
No, % (n) | 75.9 (286) | |
Laboratory exams at first RRT indication | ||
Creatinine (mg/dl) | 0.6–1.3 | 4.05 (2.90–5.60) |
Urea (mg/dl) | 16–40 | 152.8 (98.5–211.0) |
Potassium (mEq/l) | 3.5–5.1 | 4.8 (4.2–5.5) |
Bicarbonate (mEq/l) | 22–27 | 22.1 (19.0–25.9) |
Exams during the RRT period | ||
Creatinine (mg/dl) | 0.6–1.3 | 3.63 (2.12–5.10) |
Urea (mg/dl) | 16–40 | 126.5 (88.0–174.1) |
Potassium (mEq/l) | 3.5–5.1 | 4.7 (4.1–5.4) |
Bicarbonate (mEq/l) | 22–27 | 23.0 (19.6–26.0) |
RRT method | ||
Intermittent, % (n) | 56.5 (212) | |
SLED, % (n) | 8.3 (31) | |
Continuous, % (n) | 18.7 (70) | |
Combination of methods, % (n) | 16.5 (62) | |
Time on RRT (days) | 6 (2–15) | |
Outcomes | ||
Total length of stay (days) | 19 (11–30) | |
Death, % (n) | 72.5 (272) | |
Discharge without RRT, % (n) | 77.7 (80/103) | |
Discharge dependent on RRT, % (n) | 22.3 (23/103) |
Data are presented as the mean ± SD, the median and interquartile range (p25-p75), or a percentage. SLED, sustained low-efficiency dialysis.